FDASIA Workgroup Recommendations

The FDA Safety and Innovation Act (FDASIA) workgroup completed its work and made its draft recommendations in September. The recommendations include: HIT should not be regulated except in cases where there is risk to the patient, a patient-safety risk framework should be used to allow application of regulatory oversight by risk, vendors should be required to list products which represent at least some risk, better post-market surveillance of HIT is needed, steps should be taken to discourage practices that limit the free flow of information.

The committee report can be viewed here:  FDASIA Recommendations Draft 030913_v2

In addition, 39 comments were received in response to a request made by the three agencies involved (FDA, ONC and FCC). These comments can be found in Docket HHS-OS-2013-0003 at http://www.regulations.gov/#!docketBrowser;rpp=50;po=0;dct=PS;D=HHS-OS-2013-0003. The agencies have until January to complete the report.

CSV Training Course

Learn FDA expectations for software validation for computer systems, quality system software, manufacturing and production process software, and engineering tools. Email training@softwarecpr.com for more info.

Corporate Office

15148 Springview St
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN) and Italy.